loader
Please Wait
Applying Filters...

Annual Sales of Cariprazine Hydrochloride reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 20,255Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Vraylar

PharmaCompass

05

Brand Name : Vraylar

arrow
Formnext Forum
Not Confirmed

Cariprazine Hydrochloride

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 289

2016 Revenue in Millions : 94

Growth (%) : 206

Abbvie CB

06

Brand Name : Vraylar

arrow
Formnext Forum
Not Confirmed

Cariprazine Hydrochloride

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 487

2017 Revenue in Millions : 289

Growth (%) : 69%

Abbvie CB

07

Brand Name : Vraylar

arrow
Formnext Forum
Not Confirmed

Cariprazine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 858

2018 Revenue in Millions : 487

Growth (%) : 76

Abbvie CB

08

Brand Name : Vraylar

arrow
Formnext Forum
Not Confirmed

Cariprazine Hydrochloride

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 94

2015 Revenue in Millions : Not Reported

Growth (%) : New Launch

Abbvie CB